ID24568A - Kontrasepsi oral yang mengandung anti-estrogen plus progestin - Google Patents

Kontrasepsi oral yang mengandung anti-estrogen plus progestin

Info

Publication number
ID24568A
ID24568A IDW20000811A ID20000811A ID24568A ID 24568 A ID24568 A ID 24568A ID W20000811 A IDW20000811 A ID W20000811A ID 20000811 A ID20000811 A ID 20000811A ID 24568 A ID24568 A ID 24568A
Authority
ID
Indonesia
Prior art keywords
contains anti
oral contraception
estrogen plus
plus progestin
progestin
Prior art date
Application number
IDW20000811A
Other languages
English (en)
Indonesian (id)
Inventor
Michael Jay Gast
Christopher Paul Miller
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ID24568A publication Critical patent/ID24568A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20000811A 1997-11-06 1998-04-11 Kontrasepsi oral yang mengandung anti-estrogen plus progestin ID24568A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06

Publications (1)

Publication Number Publication Date
ID24568A true ID24568A (id) 2000-07-27

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000811A ID24568A (id) 1997-11-06 1998-04-11 Kontrasepsi oral yang mengandung anti-estrogen plus progestin

Country Status (28)

Country Link
EP (1) EP1051179B1 (fr)
JP (1) JP2001522798A (fr)
CN (1) CN1278732A (fr)
AR (1) AR016667A1 (fr)
AT (1) ATE304359T1 (fr)
AU (2) AU760540B2 (fr)
BG (1) BG104451A (fr)
BR (1) BR9813982A (fr)
CA (1) CA2307210A1 (fr)
CZ (1) CZ294155B6 (fr)
DE (1) DE69831605T2 (fr)
DK (1) DK1051179T3 (fr)
EA (1) EA200000492A1 (fr)
EE (1) EE04092B1 (fr)
ES (1) ES2246541T3 (fr)
GE (1) GEP20043290B (fr)
HR (1) HRP20000269A2 (fr)
HU (1) HUP0100293A3 (fr)
ID (1) ID24568A (fr)
IL (1) IL135621A0 (fr)
NO (1) NO20002167L (fr)
NZ (1) NZ503890A (fr)
PL (1) PL340623A1 (fr)
SK (1) SK6482000A3 (fr)
TR (1) TR200001268T2 (fr)
UA (1) UA68365C2 (fr)
WO (1) WO1999024027A2 (fr)
ZA (1) ZA9810136B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
EA005932B1 (ru) * 1998-05-15 2005-08-25 Уайт 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
CA2382683A1 (fr) * 1999-09-13 2001-03-22 American Home Products Corporation Conjugues glucopyranosides de 2-(4-hydroxy-phenyl)-1-{4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
JP2005504032A (ja) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法
SI1809602T1 (sl) 2004-10-27 2009-04-30 Janssen Pharmaceutica Nv Indolni derivati, uporabni kot modulatorji progesteronskega receptorja
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
RS56042B1 (sr) 2010-06-10 2017-09-29 Seragon Pharmaceuticals Inc Modulatori estrogenih receptora i njihove upotrebe
WO2013090829A1 (fr) 2011-12-14 2013-06-20 Aragon Pharmaceuticals, Inc. Modulateurs des récepteurs des œstrogènes et ses utilisations
KR20240142622A (ko) 2015-10-01 2024-09-30 올레마 파마슈티컬스 인코포레이티드 테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
LT3386500T (lt) 2015-12-09 2022-12-27 The Board Of Trustees Of The University Of Illinois Selektyvūs estrogenų receptorių slopintojai benzotiofeno pagrindu
ES2990061T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros espirocíclicos para la degradación de proteínas diana
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454856B1 (fr) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Dégronimères hétérocycliques pour la dégradation de protéines cibles
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
RU2019102647A (ru) 2016-07-01 2020-08-03 Г1 Терапьютикс, Инк. Антипролиферационные средства на основе пиримидина
WO2018081168A2 (fr) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Répresseurs du récepteur oestrogénique sélectifs mixtes à base de benzothiophène
MX2019008158A (es) 2017-01-06 2019-12-09 G1 Therapeutics Inc Terapia de combinacion para el tratamiento del cancer.
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
WO2019006393A1 (fr) 2017-06-29 2019-01-03 G1 Therapeutics, Inc. Formes morphiques de git38 et leurs procédés de fabrication
CN120698983A (zh) 2018-12-20 2025-09-26 C4医药公司 靶向蛋白降解
KR20220034129A (ko) 2019-07-07 2022-03-17 올레마 파마슈티컬스 인코포레이티드 에스트로겐 수용체 길항제 요법
KR20220119415A (ko) 2019-12-20 2022-08-29 씨4 테라퓨틱스, 인코포레이티드 Egfr 분해를 위한 이소인돌리논 및 인다졸 화합물
TW202146412A (zh) 2020-03-05 2021-12-16 美商Ｃ４醫藥公司 用於標靶降解brd9之化合物
IL300397A (en) 2020-08-05 2023-04-01 C4 Therapeutics Inc Compounds for targeted knockdown of RET
MX2023014059A (es) 2021-06-08 2024-03-12 C4 Therapeutics Inc Terapeuticos para la degradacion de una proteina quiinasa de serina/ treonina mutante.
WO2024030968A1 (fr) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Composés pour moduler la protéine ret
EP4611901A1 (fr) 2022-11-04 2025-09-10 Bristol-Myers Squibb Company Agents de dégradation de protéine ret-ldd
WO2024097980A1 (fr) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Inhibiteurs de protéines ret-ldd
EP4735452A2 (fr) 2023-06-30 2026-05-06 Merck Patent GmbH Composés hétérobifonctionnels pour la dégradation de la protéine kras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
CZ294155B6 (cs) 2004-10-13
NZ503890A (en) 2002-08-28
CN1278732A (zh) 2001-01-03
SK6482000A3 (en) 2000-11-07
AU760540B2 (en) 2003-05-15
DK1051179T3 (da) 2005-10-31
EE200000211A (et) 2001-04-16
WO1999024027A2 (fr) 1999-05-20
WO1999024027A3 (fr) 1999-07-15
ES2246541T3 (es) 2006-02-16
EA200000492A1 (ru) 2000-10-30
GEP20043290B (en) 2004-07-26
EP1051179A2 (fr) 2000-11-15
HRP20000269A2 (en) 2000-12-31
AR016667A1 (es) 2001-07-25
ATE304359T1 (de) 2005-09-15
IL135621A0 (en) 2001-05-20
AU1303199A (en) 1999-05-31
AU2003204896B2 (en) 2006-06-15
DE69831605T2 (de) 2006-06-14
EE04092B1 (et) 2003-08-15
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
ZA9810136B (en) 2000-05-05
NO20002167L (no) 2000-06-28
HUP0100293A2 (hu) 2001-10-28
BG104451A (en) 2000-12-29
TR200001268T2 (tr) 2001-01-22
EP1051179B1 (fr) 2005-09-14
DE69831605D1 (de) 2005-10-20
CA2307210A1 (fr) 1999-05-20
UA68365C2 (en) 2004-08-16
BR9813982A (pt) 2000-09-26
NO20002167D0 (no) 2000-04-27
PL340623A1 (en) 2001-02-12
CZ20001661A3 (cs) 2000-12-13

Similar Documents

Publication Publication Date Title
ID24568A (id) Kontrasepsi oral yang mengandung anti-estrogen plus progestin
AU2003204896A1 (en) Anti-estrogen plus progestin containing oral contraceptives
EP1001702A4 (fr) Ortheses
DK1140109T3 (da) Trefaset oralt antikonceptionsmiddel
HUP0103883A3 (en) New sustained release oral formulations
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
DE69821845D1 (de) Ostomievorrichtung
HUP9904345A3 (en) Oral contraceptive
AU2002218341A1 (en) Intraoral orthosis
DK0853933T3 (da) Ostomikobling
AU135502S (en) Condom
GB2336585A8 (en) Gypsum plaster
PL343428A1 (en) New contraceptive kit
ITFI970066V0 (it) Attacco ortodontico
GB9716124D0 (en) Condoms
GB9803005D0 (en) Anti-inflammatory agents
HK1029051A (en) Anti-estrogen plus progestin containing oral contraceptives
GB9804777D0 (en) Anti-inflammatory agents
UA1593S (uk) Контрацептив вагінальний
KR980000759U (ko) 콘돔
IL120398A0 (en) Low dosage contraceptive
CA85465S (en) Condom
GB9718788D0 (en) Tooth correction devices
TW319068U (en) Improved condom structure